Strategic Financial Concepts LLC Invests $1.38 Million in iShares Biotechnology ETF (NASDAQ:IBB)

Strategic Financial Concepts LLC bought a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 10,397 shares of the financial services provider’s stock, valued at approximately $1,375,000.

A number of other institutional investors have also added to or reduced their stakes in the company. Nations Financial Group Inc. IA ADV grew its position in iShares Biotechnology ETF by 8.9% during the fourth quarter. Nations Financial Group Inc. IA ADV now owns 3,080 shares of the financial services provider’s stock valued at $407,000 after acquiring an additional 251 shares during the last quarter. Bank Pictet & Cie Europe AG boosted its stake in shares of iShares Biotechnology ETF by 6.1% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 17,280 shares of the financial services provider’s stock valued at $2,285,000 after purchasing an additional 1,000 shares in the last quarter. Blue Trust Inc. grew its holdings in shares of iShares Biotechnology ETF by 22.5% during the 4th quarter. Blue Trust Inc. now owns 1,088 shares of the financial services provider’s stock valued at $144,000 after purchasing an additional 200 shares during the last quarter. Kanawha Capital Management LLC raised its position in iShares Biotechnology ETF by 6.6% in the 4th quarter. Kanawha Capital Management LLC now owns 8,939 shares of the financial services provider’s stock worth $1,182,000 after purchasing an additional 555 shares during the period. Finally, Banque Pictet & Cie SA lifted its stake in iShares Biotechnology ETF by 26.1% in the fourth quarter. Banque Pictet & Cie SA now owns 8,690 shares of the financial services provider’s stock worth $1,149,000 after purchasing an additional 1,800 shares during the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ IBB opened at $137.11 on Wednesday. The company has a 50-day simple moving average of $135.55 and a two-hundred day simple moving average of $140.81. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.